25 XP   0   0   10

Mangalam Drugs & Organics Limited
Buy, Hold or Sell?

Let's analyse Mangalam Drugs & Organics Limited together

PenkeI guess you are interested in Mangalam Drugs & Organics Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Mangalam Drugs & Organics Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Mangalam Drugs & Organics Limited

I send you an email if I find something interesting about Mangalam Drugs & Organics Limited.

Quick analysis of Mangalam Drugs & Organics Limited (30 sec.)










What can you expect buying and holding a share of Mangalam Drugs & Organics Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
INR96.00
Expected worth in 1 year
INR99.53
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR3.52
Return On Investment
3.5%

For what price can you sell your share?

Current Price per Share
INR102.03
Expected price per share
INR85.16 - INR132.40
How sure are you?
50%

1. Valuation of Mangalam Drugs & Organics Limited (5 min.)




Live pricePrice per Share (EOD)

INR102.03

Intrinsic Value Per Share

INR-84.52 - INR62.14

Total Value Per Share

INR11.48 - INR158.14

2. Growth of Mangalam Drugs & Organics Limited (5 min.)




Is Mangalam Drugs & Organics Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$18.2m$18m$167.3k0.9%

How much money is Mangalam Drugs & Organics Limited making?

Current yearPrevious yearGrowGrow %
Making money$152.4k$2.3m-$2.2m-1,447.8%
Net Profit Margin0.3%4.4%--

How much money comes from the company's main activities?

3. Financial Health of Mangalam Drugs & Organics Limited (5 min.)




4. Comparing to competitors in the Drugs - Generic industry (5 min.)




  Industry Rankings (Drugs - Generic)  

What can you expect buying and holding a share of Mangalam Drugs & Organics Limited? (5 min.)

Welcome investor! Mangalam Drugs & Organics Limited's management wants to use your money to grow the business. In return you get a share of Mangalam Drugs & Organics Limited.

What can you expect buying and holding a share of Mangalam Drugs & Organics Limited?

First you should know what it really means to hold a share of Mangalam Drugs & Organics Limited. And how you can make/lose money.

Speculation

The Price per Share of Mangalam Drugs & Organics Limited is INR102.03. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mangalam Drugs & Organics Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mangalam Drugs & Organics Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR96.00. Based on the TTM, the Book Value Change Per Share is INR0.88 per quarter. Based on the YOY, the Book Value Change Per Share is INR12.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mangalam Drugs & Organics Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.010.0%0.010.0%0.150.1%0.070.1%0.080.1%
Usd Book Value Change Per Share0.010.0%0.010.0%0.150.1%0.070.1%0.120.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.010.0%0.150.1%0.070.1%0.120.1%
Usd Price Per Share1.17-1.17-1.23-0.93-1.17-
Price to Earnings Ratio121.95-121.95-8.28-26.16-18.34-
Price-to-Total Gains Ratio111.04-111.04-8.23-24.03-16.29-
Price to Book Ratio1.02-1.02-1.08-0.94-1.81-
Price-to-Total Gains Ratio111.04-111.04-8.23-24.03-16.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.22436
Number of shares816
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.07
Usd Total Gains Per Share0.010.07
Gains per Quarter (816 shares)8.6359.62
Gains per Year (816 shares)34.52238.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1035250238228
2069600477466
30104950715704
401381300954942
50173165011921180
60207200014311418
70242235016691656
80276270019081894
90311305021462132
100345340023852370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%8.02.00.080.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%9.01.00.090.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%1.00.09.010.0%1.00.09.010.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%9.01.00.090.0%

Fundamentals of Mangalam Drugs & Organics Limited

About Mangalam Drugs & Organics Limited

Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. Mangalam Drugs & Organics Limited was incorporated in 1972 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-04-17 02:05:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Mangalam Drugs & Organics Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Mangalam Drugs & Organics Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • A Net Profit Margin of 0.3% means that ₹0.00 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.3%. The company is not making a profit/loss.
  • The TTM is 0.3%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.3%0.0%
TTM0.3%YOY4.4%-4.0%
TTM0.3%5Y2.3%-1.9%
5Y2.3%10Y3.2%-0.9%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%8.5%-8.2%
TTM0.3%8.5%-8.2%
YOY4.4%9.1%-4.7%
5Y2.3%5.6%-3.3%
10Y3.2%5.8%-2.6%
1.1.2. Return on Assets

Shows how efficient Mangalam Drugs & Organics Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • 0.4% Return on Assets means that Mangalam Drugs & Organics Limited generated ₹0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.4%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM0.4%0.0%
TTM0.4%YOY6.0%-5.6%
TTM0.4%5Y3.3%-3.0%
5Y3.3%10Y4.8%-1.5%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4%8.6%-8.2%
TTM0.4%8.6%-8.2%
YOY6.0%10.4%-4.4%
5Y3.3%5.5%-2.2%
10Y4.8%6.4%-1.6%
1.1.3. Return on Equity

Shows how efficient Mangalam Drugs & Organics Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • 0.8% Return on Equity means Mangalam Drugs & Organics Limited generated ₹0.01 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.8%0.0%
TTM0.8%YOY13.1%-12.2%
TTM0.8%5Y7.0%-6.1%
5Y7.0%10Y11.4%-4.4%
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%13.8%-13.0%
TTM0.8%13.8%-13.0%
YOY13.1%17.1%-4.0%
5Y7.0%9.2%-2.2%
10Y11.4%11.4%0.0%

1.2. Operating Efficiency of Mangalam Drugs & Organics Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Mangalam Drugs & Organics Limited is operating .

  • Measures how much profit Mangalam Drugs & Organics Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.2%-2.2%
5Y2.2%10Y6.5%-4.3%
1.2.2. Operating Ratio

Measures how efficient Mangalam Drugs & Organics Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drugs - Generic industry mean).
  • An Operation Ratio of 0.75 means that the operating costs are ₹0.75 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.754. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.754. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.754TTM0.7540.000
TTM0.754YOY0.741+0.013
TTM0.7545Y1.088-0.334
5Y1.08810Y1.330-0.242
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7540.567+0.187
TTM0.7540.567+0.187
YOY0.7410.558+0.183
5Y1.0881.087+0.001
10Y1.3301.256+0.074

1.3. Liquidity of Mangalam Drugs & Organics Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Mangalam Drugs & Organics Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drugs - Generic industry mean).
  • A Current Ratio of 1.25 means the company has ₹1.25 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 1.249. The company is just able to pay all its short-term debts.
  • The TTM is 1.249. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.249TTM1.2490.000
TTM1.249YOY1.402-0.153
TTM1.2495Y1.225+0.024
5Y1.22510Y1.228-0.003
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2491.715-0.466
TTM1.2491.715-0.466
YOY1.4021.592-0.190
5Y1.2251.381-0.156
10Y1.2281.260-0.032
1.3.2. Quick Ratio

Measures if Mangalam Drugs & Organics Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • A Quick Ratio of 0.39 means the company can pay off ₹0.39 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.386. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.386. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.386TTM0.3860.000
TTM0.386YOY0.372+0.014
TTM0.3865Y0.370+0.016
5Y0.37010Y0.419-0.049
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3860.859-0.473
TTM0.3860.859-0.473
YOY0.3720.739-0.367
5Y0.3700.644-0.274
10Y0.4190.651-0.232

1.4. Solvency of Mangalam Drugs & Organics Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Mangalam Drugs & Organics Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mangalam Drugs & Organics Limited to Drugs - Generic industry mean.
  • A Debt to Asset Ratio of 0.58 means that Mangalam Drugs & Organics Limited assets are financed with 57.7% credit (debt) and the remaining percentage (100% - 57.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.577. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.577. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.577TTM0.5770.000
TTM0.577YOY0.542+0.036
TTM0.5775Y0.544+0.033
5Y0.54410Y0.607-0.063
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5770.484+0.093
TTM0.5770.484+0.093
YOY0.5420.5420.000
5Y0.5440.544+0.000
10Y0.6070.6070.000
1.4.2. Debt to Equity Ratio

Measures if Mangalam Drugs & Organics Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • A Debt to Equity ratio of 136.7% means that company has ₹1.37 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 1.367. The company is able to pay all its debts with equity. +1
  • The TTM is 1.367. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.367TTM1.3670.000
TTM1.367YOY1.181+0.185
TTM1.3675Y1.199+0.167
5Y1.19910Y1.918-0.718
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3670.937+0.430
TTM1.3670.937+0.430
YOY1.1811.181+0.000
5Y1.1991.199+0.000
10Y1.9181.9180.000

2. Market Valuation of Mangalam Drugs & Organics Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Mangalam Drugs & Organics Limited generates.

  • Above 15 is considered overpriced but always compare Mangalam Drugs & Organics Limited to the Drugs - Generic industry mean.
  • A PE ratio of 121.95 means the investor is paying ₹121.95 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mangalam Drugs & Organics Limited:

  • The EOD is 127.162. Based on the earnings, the company is expensive. -2
  • The MRQ is 121.952. Based on the earnings, the company is expensive. -2
  • The TTM is 121.952. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD127.162MRQ121.952+5.210
MRQ121.952TTM121.9520.000
TTM121.952YOY8.281+113.671
TTM121.9525Y26.162+95.790
5Y26.16210Y18.338+7.824
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD127.16232.399+94.763
MRQ121.95225.177+96.775
TTM121.95225.177+96.775
YOY8.28122.416-14.135
5Y26.16226.162+0.000
10Y18.33818.338+0.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Mangalam Drugs & Organics Limited:

  • The EOD is 13.911. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.341. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 13.341. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD13.911MRQ13.341+0.570
MRQ13.341TTM13.3410.000
TTM13.341YOY-83.062+96.403
TTM13.3415Y-20.221+33.562
5Y-20.22110Y4.165-24.386
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD13.91113.9110.000
MRQ13.34113.3410.000
TTM13.34113.3410.000
YOY-83.06214.804-97.866
5Y-20.22117.113-37.334
10Y4.1654.165+0.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Mangalam Drugs & Organics Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drugs - Generic industry mean).
  • A PB ratio of 1.02 means the investor is paying ₹1.02 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Mangalam Drugs & Organics Limited:

  • The EOD is 1.063. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.019. Based on the equity, the company is underpriced. +1
  • The TTM is 1.019. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.063MRQ1.019+0.044
MRQ1.019TTM1.0190.000
TTM1.019YOY1.081-0.062
TTM1.0195Y0.936+0.084
5Y0.93610Y1.809-0.874
Compared to industry (Drugs - Generic)
PeriodCompanyIndustry (mean)+/- 
EOD1.0632.908-1.845
MRQ1.0192.918-1.899
TTM1.0192.918-1.899
YOY1.0813.836-2.755
5Y0.9363.175-2.239
10Y1.8093.619-1.810
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Mangalam Drugs & Organics Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8810.8810%12.494-93%6.089-86%9.600-91%
Book Value Per Share--96.00396.0030%95.122+1%79.972+20%59.166+62%
Current Ratio--1.2491.2490%1.402-11%1.225+2%1.228+2%
Debt To Asset Ratio--0.5770.5770%0.542+7%0.544+6%0.607-5%
Debt To Equity Ratio--1.3671.3670%1.181+16%1.199+14%1.918-29%
Dividend Per Share----0%-0%-0%0.050-100%
Eps--0.8020.8020%12.419-94%6.207-87%6.976-88%
Free Cash Flow Per Share--7.3357.3350%-1.238+117%5.273+39%5.031+46%
Free Cash Flow To Equity Per Share---3.164-3.1640%0.644-591%-0.521-84%-0.260-92%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--62.136--------
Intrinsic Value_10Y_min---84.519--------
Intrinsic Value_1Y_max--5.491--------
Intrinsic Value_1Y_min---1.240--------
Intrinsic Value_3Y_max--17.059--------
Intrinsic Value_3Y_min---10.010--------
Intrinsic Value_5Y_max--29.302--------
Intrinsic Value_5Y_min---25.599--------
Market Cap1614951246.000+4%1548794262.5001548794262.5000%1627935512.500-5%1220674088.500+27%1546291698.650+0%
Net Profit Margin--0.0030.0030%0.044-92%0.023-85%0.032-89%
Operating Margin----0%-0%0.022-100%0.065-100%
Operating Ratio--0.7540.7540%0.741+2%1.088-31%1.330-43%
Pb Ratio1.063+4%1.0191.0190%1.081-6%0.936+9%1.809-44%
Pe Ratio127.162+4%121.952121.9520%8.281+1373%26.162+366%18.338+565%
Price Per Share102.030+4%97.85097.8500%102.850-5%77.120+27%97.692+0%
Price To Free Cash Flow Ratio13.911+4%13.34113.3410%-83.062+723%-20.221+252%4.165+220%
Price To Total Gains Ratio115.784+4%111.041111.0410%8.232+1249%24.033+362%16.287+582%
Quick Ratio--0.3860.3860%0.372+4%0.370+4%0.419-8%
Return On Assets--0.0040.0040%0.060-94%0.033-89%0.048-93%
Return On Equity--0.0080.0080%0.131-94%0.070-88%0.114-93%
Total Gains Per Share--0.8810.8810%12.494-93%6.089-86%9.650-91%
Usd Book Value--18234744.00018234744.0000%18067368.000+1%15189727.200+20%11238002.400+62%
Usd Book Value Change Per Share--0.0110.0110%0.150-93%0.073-86%0.115-91%
Usd Book Value Per Share--1.1521.1520%1.141+1%0.960+20%0.710+62%
Usd Dividend Per Share----0%-0%-0%0.001-100%
Usd Eps--0.0100.0100%0.149-94%0.074-87%0.084-88%
Usd Free Cash Flow--1393140.0001393140.0000%-235188.000+117%1001572.800+39%955557.600+46%
Usd Free Cash Flow Per Share--0.0880.0880%-0.015+117%0.063+39%0.060+46%
Usd Free Cash Flow To Equity Per Share---0.038-0.0380%0.008-591%-0.006-84%-0.003-92%
Usd Market Cap19379414.952+4%18585531.15018585531.1500%19535226.150-5%14648089.062+27%18555500.384+0%
Usd Price Per Share1.224+4%1.1741.1740%1.234-5%0.925+27%1.172+0%
Usd Profit--152400.000152400.0000%2358900.000-94%1178880.000-87%1325037.600-88%
Usd Revenue--44670348.00044670348.0000%54128208.000-17%41121484.800+9%35208220.800+27%
Usd Total Gains Per Share--0.0110.0110%0.150-93%0.073-86%0.116-91%
 EOD+4 -4MRQTTM+0 -0YOY+10 -225Y+14 -1910Y+16 -19

3.2. Fundamental Score

Let's check the fundamental score of Mangalam Drugs & Organics Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15127.162
Price to Book Ratio (EOD)Between0-11.063
Net Profit Margin (MRQ)Greater than00.003
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.386
Current Ratio (MRQ)Greater than11.249
Debt to Asset Ratio (MRQ)Less than10.577
Debt to Equity Ratio (MRQ)Less than11.367
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.004
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Mangalam Drugs & Organics Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.754
Ma 20Greater thanMa 5099.960
Ma 50Greater thanMa 100107.663
Ma 100Greater thanMa 200104.576
OpenGreater thanClose103.350
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets3,596,288
Total Liabilities2,076,726
Total Stockholder Equity1,519,562
 As reported
Total Liabilities 2,076,726
Total Stockholder Equity+ 1,519,562
Total Assets = 3,596,288

Assets

Total Assets3,596,288
Total Current Assets2,065,841
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 4,683
Short-term Investments 72,991
Net Receivables 465,329
Inventory 1,374,665
Other Current Assets 125,518
Total Current Assets  (as reported)2,065,841
Total Current Assets  (calculated)2,043,186
+/- 22,655
Long-term Assets
Property Plant Equipment 1,335,525
Intangible Assets 182,991
Long-term Assets  (as reported)0
Long-term Assets  (calculated)1,518,516
+/- 1,518,516

Liabilities & Shareholders' Equity

Total Current Liabilities1,653,575
Long-term Liabilities0
Total Stockholder Equity1,519,562
Total Current Liabilities
Short-term Debt 495,671
Total Current Liabilities  (as reported)1,653,575
Total Current Liabilities  (calculated)495,671
+/- 1,157,904
Long-term Liabilities
Long term Debt Total 255,054
Long term Debt 187,664
Capital Lease Obligations Min Short Term Debt-495,671
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)-52,953
+/- 52,953
Total Stockholder Equity
Common Stock158,282
Retained Earnings 1,137,527
Capital Surplus 223,753
Total Stockholder Equity (as reported)1,519,562
Total Stockholder Equity (calculated)1,519,562
+/-0
Other
Cash And Equivalents22,200
Cash and Short Term Investments 99,874
Common Stock Shares Outstanding 15,828
Liabilities and Stockholders Equity 3,596,288
Net Working Capital 412,266



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
1,254,443
1,698,950
1,597,639
1,895,038
2,267,874
2,113,549
2,306,671
2,641,089
3,284,257
3,596,288
3,596,2883,284,2572,641,0892,306,6712,113,5492,267,8741,895,0381,597,6391,698,9501,254,443
   > Total Current Assets 
714,150
1,160,369
996,538
957,848
1,228,416
1,050,397
1,191,747
1,339,209
1,824,656
2,065,841
2,065,8411,824,6561,339,2091,191,7471,050,3971,228,416957,848996,5381,160,369714,150
       Cash And Cash Equivalents 
1,023
6,794
4,953
6,273
4,303
14,334
16,291
837
14,349
4,683
4,68314,34983716,29114,3344,3036,2734,9536,7941,023
       Short-term Investments 
1,792
2,402
2,401
2,439
16,561
0
0
0
0
72,991
72,991000016,5612,4392,4012,4021,792
       Net Receivables 
297,162
442,738
301,443
368,167
452,077
176,307
399,829
543,122
464,901
465,329
465,329464,901543,122399,829176,307452,077368,167301,443442,738297,162
       Inventory 
364,776
573,404
473,406
372,495
601,342
734,532
648,427
585,875
1,171,055
1,374,665
1,374,6651,171,055585,875648,427734,532601,342372,495473,406573,404364,776
       Other Current Assets 
47,727
132,032
211,022
185,368
170,569
125,136
127,104
204,203
168,794
125,518
125,518168,794204,203127,104125,136170,569185,368211,022132,03247,727
   > Long-term Assets 
0
0
0
937,189
1,037,058
1,040,864
1,114,923
0
0
0
0001,114,9231,040,8641,037,058937,189000
       Property Plant Equipment 
533,843
529,479
591,170
925,090
1,012,273
1,032,061
961,736
1,142,137
1,267,947
1,335,525
1,335,5251,267,9471,142,137961,7361,032,0611,012,273925,090591,170529,479533,843
       Intangible Assets 
0
0
0
472
7,531
4,852
61,359
99,566
138,763
182,991
182,991138,76399,56661,3594,8527,531472000
> Total Liabilities 
1,022,214
1,405,309
982,396
1,037,867
1,230,209
1,156,919
1,267,284
1,333,229
1,778,643
2,076,726
2,076,7261,778,6431,333,2291,267,2841,156,9191,230,2091,037,867982,3961,405,3091,022,214
   > Total Current Liabilities 
614,337
994,319
728,692
777,596
998,447
908,147
1,094,670
1,090,777
1,301,133
1,653,575
1,653,5751,301,1331,090,7771,094,670908,147998,447777,596728,692994,319614,337
       Short-term Debt 
771,801
779,227
353,757
413,200
507,519
505,120
418,608
511,816
470,962
495,671
495,671470,962511,816418,608505,120507,519413,200353,757779,227771,801
       Short Long Term Debt 
771,801
779,227
598,210
662,030
577,827
543,013
458,648
0
0
0
000458,648543,013577,827662,030598,210779,227771,801
       Accounts payable 
208,673
547,729
206,750
207,755
376,251
324,135
565,934
0
0
0
000565,934324,135376,251207,755206,750547,729208,673
       Other Current Liabilities 
0
0
638
1,694
10,726
2,878
18,817
0
0
0
00018,8172,87810,7261,69463800
   > Long-term Liabilities 
0
0
0
308,890
231,763
229,282
172,614
0
0
0
000172,614229,282231,763308,890000
       Long term Debt Total 
0
0
169,215
168,511
111,464
105,446
49,733
100,660
342,558
255,054
255,054342,558100,66049,733105,446111,464168,511169,21500
       Capital Lease Obligations 
0
0
0
0
0
0
19,359
0
0
0
00019,359000000
       Long-term Liabilities Other 
0
0
0
0
1
-1
5
0
0
0
0005-110000
> Total Stockholder Equity
232,229
293,641
615,243
857,171
1,037,665
956,630
1,039,387
1,307,860
1,505,614
1,519,562
1,519,5621,505,6141,307,8601,039,387956,6301,037,665857,171615,243293,641232,229
   Common Stock
131,782
131,782
143,782
158,282
158,282
158,282
158,282
158,282
158,282
158,282
158,282158,282158,282158,282158,282158,282158,282143,782131,782131,782
   Retained Earnings 
22,444
83,856
471,461
698,889
879,383
798,348
881,105
925,825
1,123,579
1,137,527
1,137,5271,123,579925,825881,105798,348879,383698,889471,46183,85622,444
   Capital Surplus 
0
0
0
0
0
0
0
223,753
223,753
223,753
223,753223,753223,7530000000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
84,825
0
0
3,801
4,033
0
0
0
0004,0333,8010084,82500



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue3,722,529
Cost of Revenue-2,807,072
Gross Profit915,457915,457
 
Operating Income (+$)
Gross Profit915,457
Operating Expense-0
Operating Income145,328915,457
 
Operating Expense (+$)
Research Development0
Selling General Administrative649,626
Selling And Marketing Expenses0
Operating Expense0649,626
 
Net Interest Income (+$)
Interest Income86,229
Interest Expense-0
Other Finance Cost-86,229
Net Interest Income0
 
Pretax Income (+$)
Operating Income145,328
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)22,138145,328
EBIT - interestExpense = 0
12,700
12,700
Interest Expense0
Earnings Before Interest and Taxes (EBIT)022,138
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax22,138
Tax Provision-9,438
Net Income From Continuing Ops012,700
Net Income12,700
Net Income Applicable To Common Shares12,700
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of Mangalam Drugs & Organics Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mangalam Drugs & Organics Limited. The general trend of Mangalam Drugs & Organics Limited is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mangalam Drugs & Organics Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Mangalam Drugs & Organics Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 104.05 < 109.00 < 132.40.

The bearish price targets are: 85.16.

Tweet this
Mangalam Drugs & Organics Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Mangalam Drugs & Organics Limited. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Mangalam Drugs & Organics Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Mangalam Drugs & Organics Limited. The current macd is -1.20968953.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mangalam Drugs & Organics Limited price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Mangalam Drugs & Organics Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Mangalam Drugs & Organics Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Mangalam Drugs & Organics Limited Daily Moving Average Convergence/Divergence (MACD) ChartMangalam Drugs & Organics Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Mangalam Drugs & Organics Limited. The current adx is 20.82.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Mangalam Drugs & Organics Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Mangalam Drugs & Organics Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Mangalam Drugs & Organics Limited. The current sar is 106.28.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Mangalam Drugs & Organics Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Mangalam Drugs & Organics Limited. The current rsi is 49.75. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Mangalam Drugs & Organics Limited Daily Relative Strength Index (RSI) ChartMangalam Drugs & Organics Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Mangalam Drugs & Organics Limited. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mangalam Drugs & Organics Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Mangalam Drugs & Organics Limited Daily Stochastic Oscillator ChartMangalam Drugs & Organics Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Mangalam Drugs & Organics Limited. The current cci is 54.69.

Mangalam Drugs & Organics Limited Daily Commodity Channel Index (CCI) ChartMangalam Drugs & Organics Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Mangalam Drugs & Organics Limited. The current cmo is 7.54661761.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Mangalam Drugs & Organics Limited Daily Chande Momentum Oscillator (CMO) ChartMangalam Drugs & Organics Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Mangalam Drugs & Organics Limited. The current willr is -29.23657718.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Mangalam Drugs & Organics Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Mangalam Drugs & Organics Limited Daily Williams %R ChartMangalam Drugs & Organics Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Mangalam Drugs & Organics Limited.

Mangalam Drugs & Organics Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Mangalam Drugs & Organics Limited. The current atr is 4.9473869.

Mangalam Drugs & Organics Limited Daily Average True Range (ATR) ChartMangalam Drugs & Organics Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Mangalam Drugs & Organics Limited. The current obv is 182,260.

Mangalam Drugs & Organics Limited Daily On-Balance Volume (OBV) ChartMangalam Drugs & Organics Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Mangalam Drugs & Organics Limited. The current mfi is 62.90.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Mangalam Drugs & Organics Limited Daily Money Flow Index (MFI) ChartMangalam Drugs & Organics Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Mangalam Drugs & Organics Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Mangalam Drugs & Organics Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Mangalam Drugs & Organics Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.754
Ma 20Greater thanMa 5099.960
Ma 50Greater thanMa 100107.663
Ma 100Greater thanMa 200104.576
OpenGreater thanClose103.350
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Mangalam Drugs & Organics Limited with someone you think should read this too:
  • Are you bullish or bearish on Mangalam Drugs & Organics Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mangalam Drugs & Organics Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Mangalam Drugs & Organics Limited

I send you an email if I find something interesting about Mangalam Drugs & Organics Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Mangalam Drugs & Organics Limited.

Receive notifications about Mangalam Drugs & Organics Limited in your mailbox!